Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses

Virology Journal

Volumn 8, Issue , 2011, Pages

  Shinya, Kyoko ^a,b   Okamura, Tadashi ^b   Sueta, Setsuko ^b   Kasai, Noriyuki ^b   Tanaka, Motoko ^a   Ginting, Teridah E ^a   Makino, Akiko ^a   Eisfeld, Amie J ^c   Kawaoka, Yoshihiro ^a,c,d,e  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; LOXORIBINE; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN FSL 1; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; MOUSE; NONHUMAN; VIRUS RESISTANCE; VIRUS TRANSMISSION; VIRUS VIRULENCE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DOG; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMALIA; AVIAN INFLUENZA VIRUS; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; CELL LINE; DOGS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VIRULENCE;

EID: 79952198162     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-97     Document Type: Article

References (29)

1. Orthomyxoviruses. P Wright G Neumann Y Kawaoka, Fields virology Philadelphia: Lippincott Williams & Wilkins, Knipe D, Howley P, Griffin D, Martin M, Lamb R, 2009 1691 1740
2. Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data. TT Bauer S Ewig AC Rodloff EE Muller, Clin Infect Dis 2006 43 748 756 10.1086/506430 16912951 (Pubitemid 44330740)
3. Hospitalized patients with 2009 H1N1 influenza infection: the Mayo Clinic experience. C Venkata P Sampathkumar B Afessa, Mayo Clin Proc 2010 85 798 805 10.4065/mcp.2010.0166 20664021
4. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. G Domínguez-Cherit SE Lapinsky AE Macias R Pinto L Espinosa-Perez A de la Torre M Poblano-Morales JA Baltazar-Torres E Bautista A Martinez MA Martinez E Rivero R Valdez G Ruiz-Palacios M Hernndez TE Stewart RA Fowler, JAMA 2009 302 1880 1887 19822626
5. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. R Perez-Padilla D de la Rosa-Zamboni S Ponce de Leon M Hernandez F Quĩones-Falconi E Bautista A Ramirez-Venegas J Rojas-Serrano CE Ormsby A Corrales A Higuera E Mondragon JA Cordova-Villalobos INER Working Group on Influenza, N Engl J Med 2009 361 680 689 10.1056/NEJMoa0904252 19564631
6. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. KY Yuen PK Chan M Peiris DN Tsang TL Que KF Shortridge PT Cheung WK To ET Ho R Sung AF Cheng, Lancet 1998 351 467 471 10.1016/S0140-6736(98)01182-9 9482437 (Pubitemid 28070092)
7. Pathology of fatal human infection associated with avian influenza A H5N1 virus. KF To PK Chan KF Chan WK Lee WY Lam KF Wong NL Tang DN Tsang RY Sung TA Buckley JS Tam AF Cheng, J Med Virol 2001 63 242 246 10.1002/1096-9071(200103) 63:3<242::AID-JMV1007>3.0.CO;2-N 11170064 (Pubitemid 32116480)
8. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. RA Fouchier PM Schneeberger FW Rozendaal JM Broekman SA Kemink V Munster T Kuiken GF Rimmelzwaan M Schutten GJ Van Doornum G Koch A Bosman M Koopmans AD Osterhaus, Proc Natl Acad Sci USA 2004 101 1356 1361 10.1073/pnas.0308352100 14745020 (Pubitemid 38182693)
9. Re-emergence of fatal human influenza A subtype H5N1 disease. JS Peiris WC Yu CW Leung CY Cheung WF Ng JM Nicholls TK Ng KH Chan ST Lai WL Lim KY Yuen Y Guan, Lancet 2004 363 617 619 10.1016/S0140-6736(04)15595-5 14987888 (Pubitemid 38264181)
10. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. MD de Jong CP Simmons TT Thanh VM Hien GJ Smith TN Chau DM Hoang NV Chau TH Khanh VC Dong PT Qui BV Cam dQ Ha Y Guan JS Peiris NT Chinh TT Hien J Farrar, Nat Med 2006 12 1203 1207 10.1038/nm1477 16964257 (Pubitemid 44527358)
11. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. D Kobasa SM Jones K Shinya JC Kash J Copps H Ebihara Y Hatta JH Kim P Halfmann M Hatta F Feldmann JB Alimonti L Fernando Y Li MG Katze H Feldmann Y Kawaoka, Nature 2007 445 319 323 10.1038/nature05495 17230189 (Pubitemid 46122819)
12. Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro. H Van Campen, Arch Virol 1994 136 439 446 10.1007/BF01321073 8031247 (Pubitemid 2101812)
13. Inhibitory Effect of TNF-alpha Produced by Macrophages Stimulated with Grifola frondosa Extract (ME) on the Growth of Influenza A/Aichi/2/68 Virus in MDCK Cells. N Obi K Hayashi T Miyahara Y Shimada K Terasawa M Watanabe M Takeyama R Obi H Ochiai, Am J Chin Med 2008 36 1171 1183 10.1142/ S0192415X08006508 19051344
14. Interferon-inducible antiviral effectors. AJ Sadler BR Williams, Nat Rev Immunol 2008 8 559 568 10.1038/nri2314 18575461 (Pubitemid 351913674)
15. Augmented lung inflammation protects against influenza A pneumonia. MJ Tuvim SE Evans CG Clement BF Dickey BE Gilbert, PLoS One 2009 4 4176 10.1371/journal.pone.0004176 19137067
16. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. T Abe H Takahashi H Hamazaki N Miyano-Kurosaki Y Matsuura H Takaku, J Immunol 2003 171 1133 1139 12874198 (Pubitemid 36900040)
17. Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. CW Cluff JR Baldridge AG Stover JT Evans DA Johnson MJ Lacy VG Clawson VM Yorgensen CL Johnson MT Livesay RM Hershberg DH Persing, Infect Immun 2005 73 3044 3052 10.1128/IAI.73.5.3044-3052.2005 15845512 (Pubitemid 40570374)
18. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine. SU Seo KH Lee YH Byun MN Kweon BL Seong, Vaccine 2007 25 8067 8076 10.1016/j.vaccine.2007.09.012 17919786 (Pubitemid 47632989)
19. Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses. JP Wong ME Christopher S Viswanathan X Dai AM Salazar LQ Sun M Wang, Curr Pharm Des 2009 15 1269 1274 10.2174/138161209787846775 19355966
20. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. D Kobasa A Takada K Shinya M Hatta P Halfmann S Theriault H Suzuki H Nishimura K Mitamura N Sugaya T Usui T Murata Y Maeda S Watanabe M Suresh T Suzuki Y Suzuki H Feldmann Y Kawaoka, Nature 2004 431 703 707 10.1038/nature02951 15470432 (Pubitemid 39382618)
21. Generation of influenza A viruses entirely from cloned cDNAs. G Neumann T Watanabe H Ito S Watanabe H Goto P Gao M Hughes DR Perez R Donis E Hoffmann G Hobom Y Kawaoka, Proc Natl Acad Sci USA 1999 96 9345 9350 10.1073/pnas.96.16. 9345 10430945 (Pubitemid 29374757)
22. A simple method of estimating fifty percent endpoints. LJ Reed H Muench, Am J Hygiene 1938 27 493 497
23. Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses. JP Wong ME Christopher AM Salazar RM Dale LQ Sun M Wang, Vaccine 2007 25 3175 3178 10.1016/j.vaccine.2007.01.051 17280757 (Pubitemid 46482750)
24. Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. L Armstrong AR Medford KM Uppington J Robertson IR Witherden TD Tetley AB Millar, Am J Respir Cell Mol Biol 2004 31 241 245 10.1165/rcmb.2004-0078OC 15044215 (Pubitemid 39095455)
25. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. M Hatta Y Hatta JH Kim S Watanabe K Shinya T Nguyen PS Lien QM Le Y Kawaoka, PLoS Pathog 2007 3 1374 1379 10.1371/journal.ppat.0030133 17922570 (Pubitemid 350085602)
26. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Y Imai K Kuba GG Neely R Yaghubian-Malhami T Perkmann LG van M Ermolaeva R Veldhuizen YH Leung H Wang H Liu Y Sun M Pasparakis M Kopf C Mech S Bavari JS Peiris AS Slutsky S Akira M Hultqvist R Holmdahl J Nicholls C Jiang CJ Binder JM Penninger, Cell 2008 133 235 249 10.1016/j.cell.2008.02.043 18423196 (Pubitemid 351512299)
27. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. EA Kurt-Jones L Popova L Kwinn LM Haynes LP Jones RA Tripp EE Walsh MW Freeman DT Golenbock LJ Anderson RW Finberg, Nat Immunol 2000 1 398 401 10.1038/80833 11062499
28. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. LM Haynes DD Moore EA Kurt-Jones RW Finberg LJ Anderson RA Tripp, J Virol 2001 75 10730 10737 10.1128/JVI.75.22.10730-10737.2001 11602714 (Pubitemid 33031542)
29. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. HA Haeberle R Takizawa A Casola AR Brasier HJ Dieterich RN Van Z Gatalica RP Garofalo, J Infect Dis 2002 186 1199 1206 10.1086/344644 12402188 (Pubitemid 35192997)